Trial intelligence / Profile preview

Remimazolam benzenesulfonate with alfentanil for analgesic endoscopy outside the operating room

ChiCTR2100046624Phase 4Recruiting

Sponsor
Zunyi Medical University Affiliated Hospital
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in bronchopulmonary diseases (3 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoints: Heart rate, Noninvasive blood pressure and 5 more. Started Aug 2020; status: recruiting.

02

Drugs

remimazolam
03

Conditions

bronchopulmonary diseases

Beyond the preview

Go deeper on ChiCTR2100046624.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100046624.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call